HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.

Abstract
The Mdm2 oncoprotein forms a complex with the p53 tumor suppressor protein and inhibits p53-mediated regulation of heterologous gene expression. Recently, Mdm2 has been found to bind several other proteins that function to regulate cell cycle progression, including the E2F-1/DP1 transcription factor complex and the retinoblastoma tumor-suppressor protein. To determine whether Mdm2 plays a role in cell cycle control or tumorigenesis that is distinct from its ability to modulate p53 function, we have examined and compared both the in vitro growth characteristics of p53-deficient and Mdm2/p53-deficient fibroblasts, and the rate and spectrum of tumor formation in p53-deficient and Mdm2/p53-deficient mice. We find no difference between p53-deficient fibroblasts and Mdm2/p53-deficient fibroblasts either in their rate of proliferation in culture or in their survival frequency when treated with various genotoxic agents. Cell cycle studies indicate no difference in the ability of the two cell populations to enter S phase when treated with DNA-damaging agents or nucleotide antimetabolites, and p53-deficient fibroblasts and Mdm2/p53-deficient fibroblasts exhibit the same rate of spontaneous immortalization following long-term passage in culture. Finally, p53-deficient mice and Mdm2/p53-deficient mice display the same incidence and spectrum of spontaneous tumor formation in vivo. These results demonstrate that deletion of Mdm2 has no additional effect on cell proliferation, cell cycle control, or tumorigenesis when p53 is absent.
AuthorsS N Jones, A T Sands, A R Hancock, H Vogel, L A Donehower, S P Linke, G M Wahl, A Bradley
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 93 Issue 24 Pg. 14106-11 (Nov 26 1996) ISSN: 0027-8424 [Print] United States
PMID8943068 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Neoplasm Proteins
  • Nuclear Proteins
  • Proto-Oncogene Proteins
  • Tumor Suppressor Protein p53
  • Mitomycin
  • Mdm2 protein, mouse
  • Proto-Oncogene Proteins c-mdm2
Topics
  • Animals
  • Cell Cycle
  • Cell Division (drug effects, radiation effects)
  • Cell Transformation, Neoplastic
  • Cells, Cultured
  • Crosses, Genetic
  • Embryo, Mammalian
  • Fibroblasts (cytology)
  • Gene Expression Regulation
  • Genotype
  • Heterozygote
  • Mice
  • Mice, Knockout
  • Mitomycin (pharmacology)
  • Neoplasm Proteins (biosynthesis)
  • Neoplasms, Experimental (genetics, physiopathology)
  • Nuclear Proteins
  • Proto-Oncogene Proteins (biosynthesis, deficiency, genetics)
  • Proto-Oncogene Proteins c-mdm2
  • Tumor Suppressor Protein p53 (biosynthesis, deficiency, genetics)
  • Ultraviolet Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: